MedTrace Logo

Overture Metabolomics Non-Selection Study

NCT04878991 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 410

Last updated 2023-11-14

No results posted yet for this study

Summary

In this study, study investigators will collect embryo culture media on day 5 of vitro fertilization (IVF) culture, prior to vitrification and embryo transfer for testing via Metabolomic screening. Metabolomics is a new, non-invasive method of embryo selection which involves testing discarded embryo culture media for analytes secreted by the developing embryo. These analytes can be used to determine the implantation potential, and ploidy, of the embryo.

This study will take place at multiple locations in the United States and Spain.

Conditions

Interventions

DIAGNOSTIC_TEST

Overture Metabolomics Embryo Selection

Patients will have their embryos selected for transfer based on morphology alone. The embryo transfer outcome will be compared to the metabolomics result to determine the NPV and PPV of metabolomics vs implantation.

Sponsors & Collaborators

  • New Hope Fertility Center

    collaborator OTHER

  • Clinica Juana Crespo

    collaborator UNKNOWN

  • Overture Life

    lead INDUSTRY

Principal Investigators

  • Jose Horcajadas, PhD · Overture Life

  • Santiago Munne, PhD · Overture Life

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-05
Primary Completion
2024-01-30
Completion
2024-01-30
FDA Device
Yes

Countries

  • United States
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04878991 on ClinicalTrials.gov